Trial intelligence / Profile preview

Mannitol for Blood Pressure Stability in Hemodialysis (MAP-HD)

NCT04428372Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Apr 2021
Primary completion
Dec 2024
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Bronchitol in intradialytic hypotension (IDH), sponsored by Brigham and Women's Hospital. Started Apr 2021; status: completed.

02

Drugs

Bronchitol
03

Conditions

intradialytic hypotension (IDH)

Beyond the preview

Go deeper on NCT04428372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04428372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call